肝癌合并动门静脉瘘的DSA表现及介入治疗

目的 :探讨肝癌合并动门静脉瘘的 DSA表现及介入治疗方案选择。方法 :对由 AFP、B超、CT诊断的原发性肝癌 95例施行了肝动脉内化疗栓塞治疗 ,治疗前均有 DSA检查。结果 :46例合并动门静脉瘘 (48.4% ) ,其中 1 7例有门脉癌栓。治疗后 AFP均有下降 ,2 7例肿瘤缩小 (58.7% ) ,1 2例肿瘤增大 (2 6.1 % ) ,7例改变不明显 (1 5.2 % )。均未发生严重肝功能损害。结论 :DSA显示动门静脉瘘准确、直观。肝癌合并动门静脉瘘影响疗效 ,但对其仍应积极治疗

DSA Appearances and Chemoembolization of Hepatoma with Arterioportal Shunt

Objective:To explore the appearances of DSA and methods of transcatheter hepatic artery chemoembolization (THACE)of hepatoma with arterioportal shunt(APS).Methods:THACE was performed in 95 patients with hepatoma comfired by AFP,ultrasound and CT.DSA was done in all patients.Results:46 patients had APS(48.4%),of them,17 patients had portal vein tumor thrombus(PVTT).After therapy AFP was decreased in all cases,the tumors were smaller in 27 (58.7%),bigger in 12(26.1%),7 cases were the same in size before and after THACE.No serious dysfunction of liver due to the treatment were happened.Conclusion:The detection of APS by DSA is accurate and direct.The therapeatic effect of hepatic cancer is influenced by APS.